Pearson
This article was originally published in The Tan Sheet
Executive Summary
Justice Department, Emord & Associates jointly move June 1 to dismiss folic acid/NTD supplement health claim litigation based on agency's allowance of claim when accompanied by disclaimer. Pearson plaintiffs also will file suit within next 60 days challenging FDA's decision to deny antioxidant vitamin/cancer claim. Complaint will target FDA's failure to evaluate disclaimer language. In its review, FDA cited studies suggesting antioxidants may have negative effect on cancer (1"The Tan Sheet" May 14, p. 10). Emord also will seek to extend Pearson to foods with new petition for low-fat pancake mix making omega-3, omega-6 fatty acids/reduced CHD risk claim; firm will file within 90 days